PTE News and Press, PolarityTE Inc. From 03/30/22

PolarityTE, Inc. (PTE) Q4 2021 Earnings Conference Call March 30, 2022 8:30 AM ET Company Participants Cameron Hoyler - General Counsel Richard Hague - Chief Executive Officer and President Jake Patterson - Chief Financial Officer Conference Call Participants Kristen Kluska - Cantor Fitzgeral...

PolarityTE press release (NASDAQ:PTE): FY GAAP EPS of -$0.38 misses by $0.06. Revenue of $9.4M (-7.2% Y/Y) beats by $1.32M. In the first quarter of 2022, PolarityTE received approval from the U.S. Food and Drug Administration (FDA) for its investigational new drug (IND) application for the ev...

PolarityTE Reports Fiscal Year 2021 Financial Results and Provides Business Update PR Newswire PolarityTE to host conference call and webcast today, March 30, 2022 , at 8:30 a.m. ET SALT LAKE CITY , March 30, 2022 /PRNewswire/ -- Polarit...

PolarityTE Announces Closing of $5.0 Million Registered Direct Offering PR Newswire SALT LAKE CITY , March 16, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) ("PolarityTE" or the "Company"), a biotechnology company developing regenerative tissue product...

PolarityTE (NASDAQ:PTE) is down 20.28% pre-market after announcing a ~$5M securities offering. The biotechnology company entered into a securities purchase agreement with a single healthcare-focused institutional investor to sell 3,000.000435 shares of Series A convertible preferred...

PolarityTE Announces $5.0 Million Registered Direct Offering PR Newswire SALT LAKE CITY , March 16, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) ("PolarityTE" or the "Company"), a biotechnology company developing regenerative tissue products and bioma...

PolarityTE to Report Fiscal Year 2021 Financial Results on March 30, 2022 PR Newswire SALT LAKE CITY , March 10, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) today announced that it will report results for the year ended December 31, 2021 , by pres...

PolarityTE (NASDAQ:PTE) received a patent from the U.S. Patent and Trademark Office for compositions that relate to the company's minimally polarized functional unit (MPFU) technology in combination with a cryoprotectant. PolarityTE said it the company's fourth patent allowance in the U.S. "P...

PolarityTE Announces Allowance of Fourth U.S. Patent PR Newswire SALT LAKE CITY , Feb. 17, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, today announced the U.S. Patent a...

Trading Penny Stocks Today? Here’s What You Need to Know With another day of trading penny stocks and blue chips here and in full effect, there is a lot for investors to keep track of. While volatility remains extremely high right now, having a consistent understanding of the lat...